Navinci (formerly Olink Bioscience), has a proud history of developing analytical techniques for nucleic acids and proteins, identifying commercial opportunities and bringing successful products to market to assist researchers in research and drug development.
Founded in 2004 with the groundbreaking innovations of Ulf Landegren and colleagues at Uppsala University, the company has directly marketed a wide range of products, including Duolink in situ protein detection, which was acquired by Sigma-Aldrich in 2016.